NCT02961985

Brief Summary

The Myocardial Infarction Register Saarland (MIR-SL), is intended to collect data about the treatment of patients suffering from ST-elevation myocardial infarction (STEMI). It aims to provide current data on the implementation of guidelines for both, the interventional and adjuvant drug therapy of STEMI in daily clinical practice in the Saarland.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
455

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2016

Longer than P75 for all trials

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 5, 2016

Completed
26 days until next milestone

Study Start

First participant enrolled

October 1, 2016

Completed
1 month until next milestone

First Posted

Study publicly available on registry

November 11, 2016

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 19, 2018

Completed
4.7 years until next milestone

Study Completion

Last participant's last visit for all outcomes

March 29, 2023

Completed
Last Updated

April 14, 2023

Status Verified

April 1, 2023

Enrollment Period

1.8 years

First QC Date

September 5, 2016

Last Update Submit

April 11, 2023

Conditions

Myocardial Infarction

Outcome Measures

Primary Outcomes (1)

  • Rate of reperfusion therapies

    Describe hospital daily routine in Germany

    24 hours

Secondary Outcomes (2)

  • Time before reperfusion therapy

    24 hours

  • In-hospital mortality

    24 hours

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients admitted to a hospital in the Saarland region with ST elevation myocardial infarction, in the last 24 hours.

You may qualify if:

  • signed informed consent

You may not qualify if:

  • age \< 18 years
  • missing informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Klinikum Saarbruecken

Saarbrücken, Saarland, 66119, Germany

Location

Marienhaus Klinikum Saarlouis-Dillingen

Dillingen, Germany

Location

Universitaetsklinikum des Saarlandes

Homburg, Germany

Location

MeSH Terms

Conditions

Myocardial Infarction

Condition Hierarchy (Ancestors)

Myocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular DiseasesInfarctionIschemiaPathologic ProcessesPathological Conditions, Signs and SymptomsNecrosis

Study Officials

  • Anselm K. Gitt, Dr.

    Stiftung Institut fuer Herzinfarktforschung

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
5 Years
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 5, 2016

First Posted

November 11, 2016

Study Start

October 1, 2016

Primary Completion

July 19, 2018

Study Completion

March 29, 2023

Last Updated

April 14, 2023

Record last verified: 2023-04

Data Sharing

IPD Sharing
Will not share

Locations

DE(3)